ESR1 and breast carcinoma: Lentinan was studied in human breast cancer cell lines of ER+ (MCF-7 and T47D) and triple-negative cell lines (MDA-MB-231 and MDA-MB-468) and inhibited only MCF-7 and T47D cell proliferation.